Krystal Biotech Q3 EPS $2.79 Vs $(1.17) Estimate, Sales $8.56M Beat $6.32M Estimate
Portfolio Pulse from Benzinga Newsdesk
Krystal Biotech reported Q3 earnings of $2.79 per share, a 338.46% increase from the same period last year. The company's quarterly sales of $8.56 million beat the analyst consensus estimate of $6.32 million.
November 06, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Krystal Biotech's Q3 earnings and sales beat estimates, indicating a strong financial performance.
Krystal Biotech's Q3 earnings per share and sales both exceeded estimates, indicating a strong financial performance. This positive financial news is likely to increase investor confidence and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100